logo
Debt-free stock Tanla Platforms shares soar almost 13% as board to consider buyback proposal on June 16

Debt-free stock Tanla Platforms shares soar almost 13% as board to consider buyback proposal on June 16

Mint2 days ago

Shares of debt-free stock Tanla Platforms surged over 11 percent in intra-day trade on Thursday, June 12, after the company informed the stock exchanges that its board of directors would meet on Monday, June 16, 2025, to consider a proposal for the buyback of equity shares. The announcement triggered a sharp rally in the stock, with investor sentiment turning positive amid expectations of shareholder-friendly corporate action.
In its regulatory filing, the company stated, 'Pursuant to Regulation 29(1)(b) of the SEBI LODR, this is to inform that a meeting of the board of directors of Tanla Platforms Limited ('Company') will be held on Monday, June 16, 2025, inter alia, to consider the proposal for buyback of equity shares of the Company and other matters necessary and incidental thereto, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws.'
If approved, this will be the third instance of Tanla Platforms pursuing a share buyback in the last five years. The company had carried out a buyback in 2020 worth ₹ 154 crore at a price of ₹ 1,200 per share. Two years later in 2022, the buyback size increased to ₹ 170 crore, although the buyback price was retained at ₹ 1,200 per share.
A buyback, or repurchase, of shares is a method by which a company buys back its own outstanding shares from existing shareholders, usually at a price higher than the current market rate. This corporate action reduces the number of shares in circulation, often boosting key financial metrics such as earnings per share (EPS) and return on equity (RoE). It also reflects the company's confidence in its future earnings potential, while serving as a tax-efficient way to return surplus capital to shareholders. In addition, a buyback can improve shareholder value by increasing the ownership percentage of remaining investors and enhancing the demand-supply equation for the stock.
The buyback proposal comes close on the heels of the company's Q4 earnings report. For the March 2025 quarter, Tanla Platforms reported a 9.9 percent decline in its net profit to ₹ 117.3 crore, compared to ₹ 130.2 crore in the same quarter of the previous fiscal year. Revenue, however, rose modestly by 1.9 percent to ₹ 1,024.4 crore from ₹ 1,005.5 crore in the year-ago period. The company's EBITDA also rose 1.9 percent to ₹ 163.4 crore, while the EBITDA margin remained steady at 16 percent.
Tanla's board had also declared a second interim dividend of ₹ 6 per equity share for FY25, with the record date for the dividend set as April 30, 2025.
The stock saw a sharp jump on June 12, rising to an intra-day high of ₹ 702.05—marking a nearly 13 percent increase. However, the stock is still over 35 percent below its 52-week high of ₹ 1,086.05, which it had touched in July 2024. The 52-week low of ₹ 409.40 was recorded in March 2025.
Over the past year, Tanla Platforms' stock has declined over 32 percent. Nevertheless, the stock has seen a turnaround since March, gaining over 12 percent in June so far and marking the fourth straight month of gains. It rose 30.6 percent in May, 1.5 percent in April, and 7 percent in March. Prior to that, the stock had been in a downtrend for six consecutive months between August 2024 and February 2025.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Natco Pharma's Mekaguda API unit completes USFDA inspection
Natco Pharma's Mekaguda API unit completes USFDA inspection

Business Standard

time10 hours ago

  • Business Standard

Natco Pharma's Mekaguda API unit completes USFDA inspection

NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active Pharmaceutical Ingredients (API) Unit The U.S. Food and Drug Administration (FDA) had conducted an inspection at the API manufacturing plant located in Mekaguda, Hyderabad, India, which was conducted from 9th June 13th June 2025. On conclusion of the inspection, the Company received 1 (One) observation in the Form-483. The Company believes that the observation is procedural in nature. The Company is confident to address this observation comprehensively.

CSB Bank gets RBI nod to reappoint Pralay Mondal as MD & CEO till 2028
CSB Bank gets RBI nod to reappoint Pralay Mondal as MD & CEO till 2028

Business Standard

time15 hours ago

  • Business Standard

CSB Bank gets RBI nod to reappoint Pralay Mondal as MD & CEO till 2028

CSB Bank announced that Reserve Bank of India (RBI) has approved the reappointment of Pralay Mondal as managing director (MD) & CEO of the bank for a period of three years with effect from 15 September 2025. The bank will now seek shareholder approval for the reappointment within the timeframe mandated under the Companies Act, 2013, and SEBI Listing Regulations. Pralay Mondal joined CSB Bank in September 2020 after serving as the head of retail banking at Axis Bank. At CSB, he initially took on the role of President overseeing retail, SME, operations, and IT, before being promoted to Deputy Managing Director in February 2022. Pralay had been the Banks interim MD and CEO since April 2022. He has earlier worked with companies like Yes Bank, HDFC Bank, Standard Chartered Bank, Wipro InfoTech and Colgate Palmolive. CSB Bank is an old private sector bank with a history of over 100 years and operates 829 branches as on 31 March 2025. The business is concentrated in Kerala with the remaining spread across Tamil Nadu, Andhra, Karnataka, and Maharashtra. The banks standalone net profit jumped 25.7% to Rs 190.44 crore on 37.4% rise in revenue form operations to Rs 1,362.36 crore in Q4 FY25 over Q4 FY24. Shares of CSB Bank fell 1.26% to Rs 384.05 on the BSE.

Board of Dilip Buildcon approves allotment of 1.53 cr equity shares on conversion of warrants
Board of Dilip Buildcon approves allotment of 1.53 cr equity shares on conversion of warrants

Business Standard

time15 hours ago

  • Business Standard

Board of Dilip Buildcon approves allotment of 1.53 cr equity shares on conversion of warrants

At meeting held on 13 June 2025 The Board of Dilip Buildcon at its meeting held on 13 June 2025 has approved the allotment of 1,53,90,510 equity shares of the Company having face value of Rs. 10/- each against receipt of the balance subscription amount of Rs. 246.03 /- per warrant (i.e. 75% of the issue price), pursuant to the exercise and conversion of 1,53,90,510 convertible warrants in compliance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 (ICDR Regulations), and the terms of allotment of the warrants.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store